Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.1K

Vascular Aging

Ruoqi Wang1, Stephen Y Chan2,3, Toren Finkel1,2

  • 1Aging Institute (R.W., T.F.), University of Pittsburgh School of Medicine, PA.

Circulation
|May 4, 2026
PubMed

Insights

Vascular aging impacts overall health and organ function, driven by cellular processes like senescence and inflammation. Targeting these vascular aging mechanisms offers potential to extend health span and improve quality of life.

Area of Science:

  • Gerontology
  • Cardiovascular Biology
  • Molecular Medicine

Background:

  • Vascular aging is a key factor in healthy lifespan, affecting cardiovascular disease risk and systemic organ health.
  • It is influenced by cellular senescence, inflammation, mitochondrial dysfunction, and epigenetic changes.
  • Vascular aging manifests as arterial stiffening, impaired barrier function, and altered vasomotor control.

Purpose of the Study:

  • To explore the multifaceted nature of vascular aging.
  • To connect vascular biology with systemic aging processes.
  • To highlight therapeutic strategies targeting vascular aging for health span extension.

Main Methods:

  • Review of recent advances in single-cell omics.
  • Analysis of cross-organ molecular clocks.
  • Examination of emerging therapeutic interventions.

Main Results:

  • Vascular aging involves complex cellular and molecular pathways interacting with the vasculature.
  • Aging exhibits heterogeneity and organ specificity, requiring integrated frameworks.
  • Therapeutic strategies targeting vascular aging show translational potential.

Conclusions:

  • Vascular aging is a critical determinant of health span, influenced by multiple biological processes.
  • Understanding vascular aging's organ-specific nature is crucial.
  • Targeting vascular aging via interventions like senolytics and metabolic therapies may enhance health span.

Keywords:
DNA damageaginginflammationmitochondriastem cells

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.1K
Assessment of Vascular Function in Patients With Chronic Kidney Disease08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
376
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
868
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.5K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
405
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35